Home » MDS Pharma, Compendia to Develop Cancer PGx Platform

MDS Pharma, Compendia to Develop Cancer PGx Platform

Apr 28, 2009

NEW YORK (GenomeWeb News) – MDS Pharma Services and Compendia Bioscience have collaborated to develop a pharmacogenomic platform for use in cancer patients and therapeutics research, MDS said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Scan

Drive Resistance

Gene drives might run into biological resistance, the Economist reports.

Dalí DNA Collected

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Synthetic-Conservation Biology Disconnect

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

This Week in Science

In Science this week: full CRISPR locus integration complex structure, and more.

What's Popular?

In Informatics

  1. Tempus, Rush University Medical Center Collaborate to Expand Hospital's Biobank

  2. Thermo Fisher's Oncomine Knowledgebase Reporter Aims to Simplify NGS Analysis

    Premium

  3. Novogene, PacBio to Codevelop Precision Medicine Applications Based on Sequel

  4. ClinGen Lists Labs Meeting Requirements for Quality Data Sharing on Genetic Variants

    Premium

  5. Three Firms Team to Offer Genomic Informatics, Cloud Storage, Research Lab

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.